R&D Can genetic data be a magic bullet for drug R&D? Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments.
Views & Analysis Overcoming the challenges of developing vaccines in an accel... The COVID-19 pandemic stopped the world in its tracks.
News FDA rejects AbbVie’s continuous Parkinson’s therapy Delay could narrow the gap between AbbVie's product and a rival system from Mitsubishi Tanabe.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK